APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical API and Intermediates

Compare research editions
View pricing & licenses

Selected research

Industry Research

Pharmaceutical API and Intermediates Industry Research Report 2026

22 December 2025142 pages

Choose your research edition.

Industry ResearchPharmaceutical API and Intermediates Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical API and Intermediates Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Pharmaceutical API and Intermediates Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical API and Intermediates Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical API and Intermediates Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Pharmaceutical API and Intermediates market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Pharmaceutical API and Intermediates is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Pharmaceutical API and Intermediates is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical API and Intermediates is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Pharmaceutical API and Intermediates include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Pharmaceutical API and Intermediates market in revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Pharmaceutical API and Intermediates.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Pharmaceutical API and Intermediates Market by Company

Lonza

BASF

Patheon

Lianhetech

Jubilant

Catalent

ABA Chem

Actylis

Chiracon

Codexis

CordenPharma

Granules India

Pfizer

Porton

Sanofi

Jiuzhou Pharmaceutical

Menohua

Puluo Pharmaceutical

Stanley

Tianyu shares

Huahai Pharmaceutical

Pharmaceutical API and Intermediates Segment by Type

API

Pharmaceutical Intermediates

Pharmaceutical API and Intermediates Segment by Application

Pharmaceutical

Feed

Food

Cosmetics

Health Products

Pharmaceutical API and Intermediates Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical API and Intermediates market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical API and Intermediates and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical API and Intermediates.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Pharmaceutical API and Intermediates manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Pharmaceutical API and Intermediates by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Pharmaceutical API and Intermediates in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Pharmaceutical API and Intermediates Production by Manufacturers (Tons) & (2021-2026) Table 6. Global Pharmaceutical API and Intermediates Production Market Share by Manufacturers Table 7. Global Pharmaceutical API and Intermediates Production Value by Manufacturers (US$ Million) & (2021-2026) Table 8. Global Pharmaceutical API and Intermediates Production Value Market Share by Manufacturers (2021-2026) Table 9. Global Pharmaceutical API and Intermediates Average Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global Pharmaceutical API and Intermediates Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pharmaceutical API and Intermediates Key Manufacturers, Manufacturing Sites & Headquarters Table 12. Global Pharmaceutical API and Intermediates Manufacturers, Product Type & Application Table 13. Global Pharmaceutical API and Intermediates Manufacturers Established Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pharmaceutical API and Intermediates by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2025) Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans Table 17. Lonza Company Information Table 18. Lonza Business Overview Table 19. Lonza Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 20. Lonza Pharmaceutical API and Intermediates Product Portfolio Table 21. Lonza Recent Development Table 22. BASF Company Information Table 23. BASF Business Overview Table 24. BASF Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 25. BASF Pharmaceutical API and Intermediates Product Portfolio Table 26. BASF Recent Development Table 27. Patheon Company Information Table 28. Patheon Business Overview Table 29. Patheon Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 30. Patheon Pharmaceutical API and Intermediates Product Portfolio Table 31. Patheon Recent Development Table 32. Lianhetech Company Information Table 33. Lianhetech Business Overview Table 34. Lianhetech Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 35. Lianhetech Pharmaceutical API and Intermediates Product Portfolio Table 36. Lianhetech Recent Development Table 37. Jubilant Company Information Table 38. Jubilant Business Overview Table 39. Jubilant Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 40. Jubilant Pharmaceutical API and Intermediates Product Portfolio Table 41. Jubilant Recent Development Table 42. Catalent Company Information Table 43. Catalent Business Overview Table 44. Catalent Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 45. Catalent Pharmaceutical API and Intermediates Product Portfolio Table 46. Catalent Recent Development Table 47. ABA Chem Company Information Table 48. ABA Chem Business Overview Table 49. ABA Chem Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 50. ABA Chem Pharmaceutical API and Intermediates Product Portfolio Table 51. ABA Chem Recent Development Table 52. Actylis Company Information Table 53. Actylis Business Overview Table 54. Actylis Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 55. Actylis Pharmaceutical API and Intermediates Product Portfolio Table 56. Actylis Recent Development Table 57. Chiracon Company Information Table 58. Chiracon Business Overview Table 59. Chiracon Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 60. Chiracon Pharmaceutical API and Intermediates Product Portfolio Table 61. Chiracon Recent Development Table 62. Codexis Company Information Table 63. Codexis Business Overview Table 64. Codexis Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 65. Codexis Pharmaceutical API and Intermediates Product Portfolio Table 66. Codexis Recent Development Table 67. CordenPharma Company Information Table 68. CordenPharma Business Overview Table 69. CordenPharma Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 70. CordenPharma Pharmaceutical API and Intermediates Product Portfolio Table 71. CordenPharma Recent Development Table 72. Granules India Company Information Table 73. Granules India Business Overview Table 74. Granules India Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 75. Granules India Pharmaceutical API and Intermediates Product Portfolio Table 76. Granules India Recent Development Table 77. Pfizer Company Information Table 78. Pfizer Business Overview Table 79. Pfizer Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 80. Pfizer Pharmaceutical API and Intermediates Product Portfolio Table 81. Pfizer Recent Development Table 82. Porton Company Information Table 83. Porton Business Overview Table 84. Porton Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 85. Porton Pharmaceutical API and Intermediates Product Portfolio Table 86. Porton Recent Development Table 87. Sanofi Company Information Table 88. Sanofi Business Overview Table 89. Sanofi Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 90. Sanofi Pharmaceutical API and Intermediates Product Portfolio Table 91. Sanofi Recent Development Table 92. Jiuzhou Pharmaceutical Company Information Table 93. Jiuzhou Pharmaceutical Business Overview Table 94. Jiuzhou Pharmaceutical Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 95. Jiuzhou Pharmaceutical Pharmaceutical API and Intermediates Product Portfolio Table 96. Jiuzhou Pharmaceutical Recent Development Table 97. Menohua Company Information Table 98. Menohua Business Overview Table 99. Menohua Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 100. Menohua Pharmaceutical API and Intermediates Product Portfolio Table 101. Menohua Recent Development Table 102. Puluo Pharmaceutical Company Information Table 103. Puluo Pharmaceutical Business Overview Table 104. Puluo Pharmaceutical Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 105. Puluo Pharmaceutical Pharmaceutical API and Intermediates Product Portfolio Table 106. Puluo Pharmaceutical Recent Development Table 107. Stanley Company Information Table 108. Stanley Business Overview Table 109. Stanley Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 110. Stanley Pharmaceutical API and Intermediates Product Portfolio Table 111. Stanley Recent Development Table 112. Tianyu shares Company Information Table 113. Tianyu shares Business Overview Table 114. Tianyu shares Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 115. Tianyu shares Pharmaceutical API and Intermediates Product Portfolio Table 116. Tianyu shares Recent Development Table 117. Huahai Pharmaceutical Company Information Table 118. Huahai Pharmaceutical Business Overview Table 119. Huahai Pharmaceutical Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 120. Huahai Pharmaceutical Pharmaceutical API and Intermediates Product Portfolio Table 121. Huahai Pharmaceutical Recent Development Table 122. Global Pharmaceutical API and Intermediates Production Comparison by Region: 2021 VS 2025 VS 2032 (Tons) Table 123. Global Pharmaceutical API and Intermediates Production by Region (2021-2026) & (Tons) Table 124. Global Pharmaceutical API and Intermediates Production Market Share by Region (2021-2026) Table 125. Global Pharmaceutical API and Intermediates Production Forecast by Region (2027-2032) & (Tons) Table 126. Global Pharmaceutical API and Intermediates Production Market Share Forecast by Region (2027-2032) Table 127. Global Pharmaceutical API and Intermediates Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Global Pharmaceutical API and Intermediates Production Value by Region (2021-2026) & (US$ Million) Table 129. Global Pharmaceutical API and Intermediates Production Value Market Share by Region (2021-2026) Table 130. Global Pharmaceutical API and Intermediates Production Value Forecast by Region (2027-2032) & (US$ Million) Table 131. Global Pharmaceutical API and Intermediates Market Average Price (US$/Ton) by Region (2021-2026) Table 132. Global Pharmaceutical API and Intermediates Market Average Price (US$/Ton) by Region (2027-2032) Table 133. Global Pharmaceutical API and Intermediates Consumption Comparison by Region: 2021 VS 2025 VS 2032 (Tons) Table 134. Global Pharmaceutical API and Intermediates Consumption by Region (2021-2026) & (Tons) Table 135. Global Pharmaceutical API and Intermediates Consumption Market Share by Region (2021-2026) Table 136. Global Pharmaceutical API and Intermediates Forecasted Consumption by Region (2027-2032) & (Tons) Table 137. Global Pharmaceutical API and Intermediates Forecasted Consumption Market Share by Region (2027-2032) Table 138. North America Pharmaceutical API and Intermediates Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 139. North America Pharmaceutical API and Intermediates Consumption by Country (2021-2026) & (Tons) Table 140. North America Pharmaceutical API and Intermediates Consumption by Country (2027-2032) & (Tons) Table 141. Europe Pharmaceutical API and Intermediates Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 142. Europe Pharmaceutical API and Intermediates Consumption by Country (2021-2026) & (Tons) Table 143. Europe Pharmaceutical API and Intermediates Consumption by Country (2027-2032) & (Tons) Table 144. Asia Pacific Pharmaceutical API and Intermediates Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 145. Asia Pacific Pharmaceutical API and Intermediates Consumption by Country (2021-2026) & (Tons) Table 146. Asia Pacific Pharmaceutical API and Intermediates Consumption by Country (2027-2032) & (Tons) Table 147. South America, Middle East & Africa Pharmaceutical API and Intermediates Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 148. South America, Middle East & Africa Pharmaceutical API and Intermediates Consumption by Country (2021-2026) & (Tons) Table 149. South America, Middle East & Africa Pharmaceutical API and Intermediates Consumption by Country (2027-2032) & (Tons) Table 150. Global Pharmaceutical API and Intermediates Production by Type (2021-2026) & (Tons) Table 151. Global Pharmaceutical API and Intermediates Production by Type (2027-2032) & (Tons) Table 152. Global Pharmaceutical API and Intermediates Production Market Share by Type (2021-2026) Table 153. Global Pharmaceutical API and Intermediates Production Market Share by Type (2027-2032) Table 154. Global Pharmaceutical API and Intermediates Production Value by Type (2021-2026) & (US$ Million) Table 155. Global Pharmaceutical API and Intermediates Production Value by Type (2027-2032) & (US$ Million) Table 156. Global Pharmaceutical API and Intermediates Production Value Market Share by Type (2021-2026) Table 157. Global Pharmaceutical API and Intermediates Production Value Market Share by Type (2027-2032) Table 158. Global Pharmaceutical API and Intermediates Price by Type (2021-2026) & (US$/Ton) Table 159. Global Pharmaceutical API and Intermediates Price by Type (2027-2032) & (US$/Ton) Table 160. Global Pharmaceutical API and Intermediates Production by Application (2021-2026) & (Tons) Table 161. Global Pharmaceutical API and Intermediates Production by Application (2027-2032) & (Tons) Table 162. Global Pharmaceutical API and Intermediates Production Market Share by Application (2021-2026) Table 163. Global Pharmaceutical API and Intermediates Production Market Share by Application (2027-2032) Table 164. Global Pharmaceutical API and Intermediates Production Value by Application (2021-2026) & (US$ Million) Table 165. Global Pharmaceutical API and Intermediates Production Value by Application (2027-2032) & (US$ Million) Table 166. Global Pharmaceutical API and Intermediates Production Value Market Share by Application (2021-2026) Table 167. Global Pharmaceutical API and Intermediates Production Value Market Share by Application (2027-2032) Table 168. Global Pharmaceutical API and Intermediates Price by Application (2021-2026) & (US$/Ton) Table 169. Global Pharmaceutical API and Intermediates Price by Application (2027-2032) & (US$/Ton) Table 170. Key Raw Materials Table 171. Raw Materials Key Suppliers Table 172. Pharmaceutical API and Intermediates Distributors List Table 173. Pharmaceutical API and Intermediates Customers List Table 174. Pharmaceutical API and Intermediates Industry Trends Table 175. Pharmaceutical API and Intermediates Industry Drivers Table 176. Pharmaceutical API and Intermediates Industry Restraints Table 177. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Pharmaceutical API and Intermediates Product Image Figure 5. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. API Product Image Figure 7. Pharmaceutical Intermediates Product Image Figure 8. Pharmaceutical Product Image Figure 9. Feed Product Image Figure 10. Food Product Image Figure 11. Cosmetics Product Image Figure 12. Health Products Product Image Figure 13. Global Pharmaceutical API and Intermediates Production Value (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Pharmaceutical API and Intermediates Production Value (2021-2032) & (US$ Million) Figure 15. Global Pharmaceutical API and Intermediates Production Capacity (2021-2032) & (Tons) Figure 16. Global Pharmaceutical API and Intermediates Production (2021-2032) & (Tons) Figure 17. Global Pharmaceutical API and Intermediates Average Price (US$/Ton) & (2021-2032) Figure 18. Global Pharmaceutical API and Intermediates Key Manufacturers, Manufacturing Sites & Headquarters Figure 19. Global Top 5 and 10 Pharmaceutical API and Intermediates Players Market Share by Production Value in 2025 Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Pharmaceutical API and Intermediates Production Comparison by Region: 2021 VS 2025 VS 2032 (Tons) Figure 22. Global Pharmaceutical API and Intermediates Production Market Share by Region: 2021 VS 2025 VS 2032 Figure 23. Global Pharmaceutical API and Intermediates Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 24. Global Pharmaceutical API and Intermediates Production Value Market Share by Region: 2021 VS 2025 VS 2032 Figure 25. North America Pharmaceutical API and Intermediates Production Value (US$ Million) Growth Rate (2021-2032) Figure 26. Europe Pharmaceutical API and Intermediates Production Value (US$ Million) Growth Rate (2021-2032) Figure 27. China Pharmaceutical API and Intermediates Production Value (US$ Million) Growth Rate (2021-2032) Figure 28. Japan Pharmaceutical API and Intermediates Production Value (US$ Million) Growth Rate (2021-2032) Figure 29. Global Pharmaceutical API and Intermediates Consumption Comparison by Region: 2021 VS 2025 VS 2032 (Tons) Figure 30. Global Pharmaceutical API and Intermediates Consumption Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 32. North America Pharmaceutical API and Intermediates Consumption Market Share by Country (2021-2032) Figure 33. United States Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 34. United States Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 35. Canada Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 36. Mexico Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 37. Europe Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 38. Europe Pharmaceutical API and Intermediates Consumption Market Share by Country (2021-2032) Figure 39. Germany Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 40. France Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 41. U.K. Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 42. Italy Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 43. Russia Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 44. Spain Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 45. Netherlands Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 46. Switzerland Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 47. Sweden Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 48. Poland Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 49. Asia Pacific Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 50. Asia Pacific Pharmaceutical API and Intermediates Consumption Market Share by Country (2021-2032) Figure 51. China Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 52. Japan Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 53. South Korea Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 54. India Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 55. Australia Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 56. Taiwan Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 57. Southeast Asia Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 58. South America, Middle East & Africa Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 59. South America, Middle East & Africa Pharmaceutical API and Intermediates Consumption Market Share by Country (2021-2032) Figure 60. Brazil Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 61. Argentina Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 62. Chile Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 63. Turkey Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 64. GCC Countries Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 65. Global Pharmaceutical API and Intermediates Production Market Share by Type (2021-2032) Figure 66. Global Pharmaceutical API and Intermediates Production Value Market Share by Type (2021-2032) Figure 67. Global Pharmaceutical API and Intermediates Price (US$/Ton) by Type (2021-2032) Figure 68. Global Pharmaceutical API and Intermediates Production Market Share by Application (2021-2032) Figure 69. Global Pharmaceutical API and Intermediates Production Value Market Share by Application (2021-2032) Figure 70. Global Pharmaceutical API and Intermediates Price (US$/Ton) by Application (2021-2032) Figure 71. Pharmaceutical API and Intermediates Value Chain Figure 72. Pharmaceutical API and Intermediates Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Pharmaceutical API and Intermediates Industry Opportunities and Challenges

Scope & coverage.

Types
  • API
  • Pharmaceutical Intermediates
Applications
  • Pharmaceutical
  • Feed
  • Food
  • Cosmetics
  • Health Products
Companies covered
  • Lonza
  • BASF
  • Patheon
  • Lianhetech
  • Jubilant
  • Catalent
  • ABA Chem
  • Actylis
  • Chiracon
  • Codexis
  • CordenPharma
  • Granules India
  • Pfizer
  • Porton
  • Sanofi
  • Jiuzhou Pharmaceutical
  • Menohua
  • Puluo Pharmaceutical
  • Stanley
  • Tianyu shares
  • Huahai Pharmaceutical

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Pharmaceutical API and Intermediates by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  4. 2.2.2 API
  5. 2.2.3 Pharmaceutical Intermediates
  6. 2.3 Pharmaceutical API and Intermediates by Application
  7. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Pharmaceutical
  9. 2.3.3 Feed
  10. 2.3.4 Food
  11. 2.3.5 Cosmetics
  12. 2.3.6 Health Products
  13. 2.4 Global Market Growth Prospects
  14. 2.4.1 Global Pharmaceutical API and Intermediates Production Value Estimates and Forecasts (2021-2032)
  15. 2.4.2 Global Pharmaceutical API and Intermediates Production Capacity Estimates and Forecasts (2021-2032)
  16. 2.4.3 Global Pharmaceutical API and Intermediates Production Estimates and Forecasts (2021-2032)
  17. 2.4.4 Global Pharmaceutical API and Intermediates Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Pharmaceutical API and Intermediates Production by Manufacturers (2021-2026)
  2. 3.2 Global Pharmaceutical API and Intermediates Production Value by Manufacturers (2021-2026)
  3. 3.3 Global Pharmaceutical API and Intermediates Average Price by Manufacturers (2021-2026)
  4. 3.4 Global Pharmaceutical API and Intermediates Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pharmaceutical API and Intermediates Key Manufacturers, Manufacturing Sites & Headquarters
  6. 3.6 Global Pharmaceutical API and Intermediates Manufacturers, Product Type & Application
  7. 3.7 Global Pharmaceutical API and Intermediates Manufacturers Established Date
  8. 3.8 Global Pharmaceutical API and Intermediates Market CR5 and HHI
  9. 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Lonza
  2. 4.1.1 Lonza Pharmaceutical API and Intermediates Company Information
  3. 4.1.2 Lonza Pharmaceutical API and Intermediates Business Overview
  4. 4.1.3 Lonza Pharmaceutical API and Intermediates Production Capacity, Value and Gross Margin (2021-2026)
  5. 4.1.4 Lonza Product Portfolio
  6. 4.1.5 Lonza Recent Developments
  7. 4.2 BASF
  8. 4.2.1 BASF Pharmaceutical API and Intermediates Company Information
  9. 4.2.2 BASF Pharmaceutical API and Intermediates Business Overview
  10. 4.2.3 BASF Pharmaceutical API and Intermediates Production Capacity, Value and Gross Margin (2021-2026)
  11. 4.2.4 BASF Product Portfolio
  12. 4.2.5 BASF Recent Developments
  13. 4.3 Patheon
  14. 4.3.1 Patheon Pharmaceutical API and Intermediates Company Information
  15. 4.3.2 Patheon Pharmaceutical API and Intermediates Business Overview
  16. 4.3.3 Patheon Pharmaceutical API and Intermediates Production Capacity, Value and Gross Margin (2021-2026)
  17. 4.3.4 Patheon Product Portfolio
  18. 4.3.5 Patheon Recent Developments
  19. 4.4 Lianhetech
  20. 4.4.1 Lianhetech Pharmaceutical API and Intermediates Company Information
  21. 4.4.2 Lianhetech Pharmaceutical API and Intermediates Business Overview
  22. 4.4.3 Lianhetech Pharmaceutical API and Intermediates Production Capacity, Value and Gross Margin (2021-2026)
  23. 4.4.4 Lianhetech Product Portfolio
  24. 4.4.5 Lianhetech Recent Developments
  25. 4.5 Jubilant
  26. 4.5.1 Jubilant Pharmaceutical API and Intermediates Company Information
  27. 4.5.2 Jubilant Pharmaceutical API and Intermediates Business Overview
  28. 4.5.3 Jubilant Pharmaceutical API and Intermediates Production Capacity, Value and Gross Margin (2021-2026)
  29. 4.5.4 Jubilant Product Portfolio
  30. 4.5.5 Jubilant Recent Developments
  31. 4.6 Catalent
  32. 4.6.1 Catalent Pharmaceutical API and Intermediates Company Information
  33. 4.6.2 Catalent Pharmaceutical API and Intermediates Business Overview
  34. 4.6.3 Catalent Pharmaceutical API and Intermediates Production Capacity, Value and Gross Margin (2021-2026)
  35. 4.6.4 Catalent Product Portfolio
  36. 4.6.5 Catalent Recent Developments
  37. 4.7 ABA Chem
  38. 4.7.1 ABA Chem Pharmaceutical API and Intermediates Company Information
  39. 4.7.2 ABA Chem Pharmaceutical API and Intermediates Business Overview
  40. 4.7.3 ABA Chem Pharmaceutical API and Intermediates Production Capacity, Value and Gross Margin (2021-2026)
  41. 4.7.4 ABA Chem Product Portfolio
  42. 4.7.5 ABA Chem Recent Developments
  43. 4.8 Actylis
  44. 4.8.1 Actylis Pharmaceutical API and Intermediates Company Information
  45. 4.8.2 Actylis Pharmaceutical API and Intermediates Business Overview
  46. 4.8.3 Actylis Pharmaceutical API and Intermediates Production Capacity, Value and Gross Margin (2021-2026)
  47. 4.8.4 Actylis Product Portfolio
  48. 4.8.5 Actylis Recent Developments
  49. 4.9 Chiracon
  50. 4.9.1 Chiracon Pharmaceutical API and Intermediates Company Information
  51. 4.9.2 Chiracon Pharmaceutical API and Intermediates Business Overview
  52. 4.9.3 Chiracon Pharmaceutical API and Intermediates Production Capacity, Value and Gross Margin (2021-2026)
  53. 4.9.4 Chiracon Product Portfolio
  54. 4.9.5 Chiracon Recent Developments
  55. 4.10 Codexis
  56. 4.10.1 Codexis Pharmaceutical API and Intermediates Company Information
  57. 4.10.2 Codexis Pharmaceutical API and Intermediates Business Overview
  58. 4.10.3 Codexis Pharmaceutical API and Intermediates Production Capacity, Value and Gross Margin (2021-2026)
  59. 4.10.4 Codexis Product Portfolio
  60. 4.10.5 Codexis Recent Developments
  61. 4.11 CordenPharma
  62. 4.11.1 CordenPharma Pharmaceutical API and Intermediates Company Information
  63. 4.11.2 CordenPharma Pharmaceutical API and Intermediates Business Overview
  64. 4.11.3 CordenPharma Pharmaceutical API and Intermediates Production Capacity, Value and Gross Margin (2021-2026)
  65. 4.11.4 CordenPharma Product Portfolio
  66. 4.11.5 CordenPharma Recent Developments
  67. 4.12 Granules India
  68. 4.12.1 Granules India Pharmaceutical API and Intermediates Company Information
  69. 4.12.2 Granules India Pharmaceutical API and Intermediates Business Overview
  70. 4.12.3 Granules India Pharmaceutical API and Intermediates Production Capacity, Value and Gross Margin (2021-2026)
  71. 4.12.4 Granules India Product Portfolio
  72. 4.12.5 Granules India Recent Developments
  73. 4.13 Pfizer
  74. 4.13.1 Pfizer Pharmaceutical API and Intermediates Company Information
  75. 4.13.2 Pfizer Pharmaceutical API and Intermediates Business Overview
  76. 4.13.3 Pfizer Pharmaceutical API and Intermediates Production Capacity, Value and Gross Margin (2021-2026)
  77. 4.13.4 Pfizer Product Portfolio
  78. 4.13.5 Pfizer Recent Developments
  79. 4.14 Porton
  80. 4.14.1 Porton Pharmaceutical API and Intermediates Company Information
  81. 4.14.2 Porton Pharmaceutical API and Intermediates Business Overview
  82. 4.14.3 Porton Pharmaceutical API and Intermediates Production Capacity, Value and Gross Margin (2021-2026)
  83. 4.14.4 Porton Product Portfolio
  84. 4.14.5 Porton Recent Developments
  85. 4.15 Sanofi
  86. 4.15.1 Sanofi Pharmaceutical API and Intermediates Company Information
  87. 4.15.2 Sanofi Pharmaceutical API and Intermediates Business Overview
  88. 4.15.3 Sanofi Pharmaceutical API and Intermediates Production Capacity, Value and Gross Margin (2021-2026)
  89. 4.15.4 Sanofi Product Portfolio
  90. 4.15.5 Sanofi Recent Developments
  91. 4.16 Jiuzhou Pharmaceutical
  92. 4.16.1 Jiuzhou Pharmaceutical Pharmaceutical API and Intermediates Company Information
  93. 4.16.2 Jiuzhou Pharmaceutical Pharmaceutical API and Intermediates Business Overview
  94. 4.16.3 Jiuzhou Pharmaceutical Pharmaceutical API and Intermediates Production Capacity, Value and Gross Margin (2021-2026)
  95. 4.16.4 Jiuzhou Pharmaceutical Product Portfolio
  96. 4.16.5 Jiuzhou Pharmaceutical Recent Developments
  97. 4.17 Menohua
  98. 4.17.1 Menohua Pharmaceutical API and Intermediates Company Information
  99. 4.17.2 Menohua Pharmaceutical API and Intermediates Business Overview
  100. 4.17.3 Menohua Pharmaceutical API and Intermediates Production Capacity, Value and Gross Margin (2021-2026)
  101. 4.17.4 Menohua Product Portfolio
  102. 4.17.5 Menohua Recent Developments
  103. 4.18 Puluo Pharmaceutical
  104. 4.18.1 Puluo Pharmaceutical Pharmaceutical API and Intermediates Company Information
  105. 4.18.2 Puluo Pharmaceutical Pharmaceutical API and Intermediates Business Overview
  106. 4.18.3 Puluo Pharmaceutical Pharmaceutical API and Intermediates Production Capacity, Value and Gross Margin (2021-2026)
  107. 4.18.4 Puluo Pharmaceutical Product Portfolio
  108. 4.18.5 Puluo Pharmaceutical Recent Developments
  109. 4.19 Stanley
  110. 4.19.1 Stanley Pharmaceutical API and Intermediates Company Information
  111. 4.19.2 Stanley Pharmaceutical API and Intermediates Business Overview
  112. 4.19.3 Stanley Pharmaceutical API and Intermediates Production Capacity, Value and Gross Margin (2021-2026)
  113. 4.19.4 Stanley Product Portfolio
  114. 4.19.5 Stanley Recent Developments
  115. 4.20 Tianyu shares
  116. 4.20.1 Tianyu shares Pharmaceutical API and Intermediates Company Information
  117. 4.20.2 Tianyu shares Pharmaceutical API and Intermediates Business Overview
  118. 4.20.3 Tianyu shares Pharmaceutical API and Intermediates Production Capacity, Value and Gross Margin (2021-2026)
  119. 4.20.4 Tianyu shares Product Portfolio
  120. 4.20.5 Tianyu shares Recent Developments
  121. 4.21 Huahai Pharmaceutical
  122. 4.21.1 Huahai Pharmaceutical Pharmaceutical API and Intermediates Company Information
  123. 4.21.2 Huahai Pharmaceutical Pharmaceutical API and Intermediates Business Overview
  124. 4.21.3 Huahai Pharmaceutical Pharmaceutical API and Intermediates Production Capacity, Value and Gross Margin (2021-2026)
  125. 4.21.4 Huahai Pharmaceutical Product Portfolio
  126. 4.21.5 Huahai Pharmaceutical Recent Developments
5 Global Pharmaceutical API and Intermediates Production by Region
  1. 5.1 Global Pharmaceutical API and Intermediates Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Pharmaceutical API and Intermediates Production by Region: 2021-2032
  3. 5.2.1 Global Pharmaceutical API and Intermediates Production by Region: 2021-2026
  4. 5.2.2 Global Pharmaceutical API and Intermediates Production Forecast by Region (2027-2032)
  5. 5.3 Global Pharmaceutical API and Intermediates Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  6. 5.4 Global Pharmaceutical API and Intermediates Production Value by Region: 2021-2032
  7. 5.4.1 Global Pharmaceutical API and Intermediates Production Value by Region: 2021-2026
  8. 5.4.2 Global Pharmaceutical API and Intermediates Production Value Forecast by Region (2027-2032)
  9. 5.5 Global Pharmaceutical API and Intermediates Market Price Analysis by Region (2021-2026)
  10. 5.6 Global Pharmaceutical API and Intermediates Production and Value, YOY Growth
  11. 5.6.1 North America Pharmaceutical API and Intermediates Production Value Estimates and Forecasts (2021-2032)
  12. 5.6.2 Europe Pharmaceutical API and Intermediates Production Value Estimates and Forecasts (2021-2032)
  13. 5.6.3 China Pharmaceutical API and Intermediates Production Value Estimates and Forecasts (2021-2032)
  14. 5.6.4 Japan Pharmaceutical API and Intermediates Production Value Estimates and Forecasts (2021-2032)
6 Global Pharmaceutical API and Intermediates Consumption by Region
  1. 6.1 Global Pharmaceutical API and Intermediates Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmaceutical API and Intermediates Consumption by Region (2021-2032)
  3. 6.2.1 Global Pharmaceutical API and Intermediates Consumption by Region: 2021-2026
  4. 6.2.2 Global Pharmaceutical API and Intermediates Forecasted Consumption by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pharmaceutical API and Intermediates Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pharmaceutical API and Intermediates Consumption by Country (2021-2032)
  8. 6.3.3 United States
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pharmaceutical API and Intermediates Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pharmaceutical API and Intermediates Consumption by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Russia
  19. 6.4.8 Spain
  20. 6.4.9 Netherlands
  21. 6.4.10 Switzerland
  22. 6.4.11 Sweden
  23. 6.4.12 Poland
  24. 6.5 Asia Pacific
  25. 6.5.1 Asia Pacific Pharmaceutical API and Intermediates Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  26. 6.5.2 Asia Pacific Pharmaceutical API and Intermediates Consumption by Country (2021-2032)
  27. 6.5.3 China
  28. 6.5.4 Japan
  29. 6.5.5 South Korea
  30. 6.5.6 India
  31. 6.5.7 Australia
  32. 6.5.8 Taiwan
  33. 6.5.9 Southeast Asia
  34. 6.6 South America, Middle East & Africa
  35. 6.6.1 South America, Middle East & Africa Pharmaceutical API and Intermediates Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  36. 6.6.2 South America, Middle East & Africa Pharmaceutical API and Intermediates Consumption by Country (2021-2032)
  37. 6.6.3 Brazil
  38. 6.6.4 Argentina
  39. 6.6.5 Chile
  40. 6.6.6 Turkey
  41. 6.6.7 GCC Countries
7 Segment by Type
  1. 7.1 Global Pharmaceutical API and Intermediates Production by Type (2021-2032)
  2. 7.1.1 Global Pharmaceutical API and Intermediates Production by Type (2021-2032) & (Tons)
  3. 7.1.2 Global Pharmaceutical API and Intermediates Production Market Share by Type (2021-2032)
  4. 7.2 Global Pharmaceutical API and Intermediates Production Value by Type (2021-2032)
  5. 7.2.1 Global Pharmaceutical API and Intermediates Production Value by Type (2021-2032) & (US$ Million)
  6. 7.2.2 Global Pharmaceutical API and Intermediates Production Value Market Share by Type (2021-2032)
  7. 7.3 Global Pharmaceutical API and Intermediates Price by Type (2021-2032)
8 Segment by Application
  1. 8.1 Global Pharmaceutical API and Intermediates Production by Application (2021-2032)
  2. 8.1.1 Global Pharmaceutical API and Intermediates Production by Application (2021-2032) & (Tons)
  3. 8.1.2 Global Pharmaceutical API and Intermediates Production Market Share by Application (2021-2032)
  4. 8.2 Global Pharmaceutical API and Intermediates Production Value by Application (2021-2032)
  5. 8.2.1 Global Pharmaceutical API and Intermediates Production Value by Application (2021-2032) & (US$ Million)
  6. 8.2.2 Global Pharmaceutical API and Intermediates Production Value Market Share by Application (2021-2032)
  7. 8.3 Global Pharmaceutical API and Intermediates Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
  1. 9.1 Pharmaceutical API and Intermediates Value Chain Analysis
  2. 9.1.1 Pharmaceutical API and Intermediates Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Pharmaceutical API and Intermediates Production Mode & Process
  5. 9.2 Pharmaceutical API and Intermediates Sales Channels Analysis
  6. 9.2.1 Direct Comparison with Distribution Share
  7. 9.2.2 Pharmaceutical API and Intermediates Distributors
  8. 9.2.3 Pharmaceutical API and Intermediates Customers
10 Global Pharmaceutical API and Intermediates Analyzing Market Dynamics
  1. 10.1 Pharmaceutical API and Intermediates Industry Trends
  2. 10.2 Pharmaceutical API and Intermediates Industry Drivers
  3. 10.3 Pharmaceutical API and Intermediates Industry Opportunities and Challenges
  4. 10.4 Pharmaceutical API and Intermediates Industry Restraints
11 Report Conclusion
    12 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst